2026-2027 Women’s Health Seminar Series

The Women’s Health Research Cluster’s Women’s Health Seminar Series offers you the opportunity to expand your breadth of knowledge about women’s health by attending monthly seminars that bring you the latest multidisciplinary research from experts around the world. Each seminar includes a 45 minute lecture by a leading expert, followed by an interactive 15 minute dialogue where you get to engage with the speaker.

You are welcome to attend one session, or join us for all–they are all free! Those who attend 75% or more seminars will receive a certificate to honour their achievement.

Name(Required)
Email(Required)
Which Seminars would you like to attend?(Required)

Click Below for Individual Seminar Details

Drinking to Belong? Alcohol Advertising as a Women’s and LGBTQ+ Health Issue

September 14th, 2026 | 12pm

Gender, sexuality, and other social determinants of health shape whether, what, and how people drink alcohol. In addition, consuming alcohol is a way of signalling ‘who we are’. Women have traditionally consumed less alcohol than men, but this gap is closing, while LGBTQ+ people consistently show higher rates of heavy drinking than heterosexual and cisgender peers.

Drawing on qualitative research, this seminar will demonstrate how both women and LGBTQ+ people connect drinking to identity— and how the alcohol industry has learned to capitalize on this. Marketing has shifted from objectifying women to sell alcohol to men, toward selling directly to women and LGBTQ+ communities through messages of empowerment, friendship, and solidarity. The seminar concludes with examples of how this research has directly shaped alcohol policy in the UK.

Professor Carol Emslie

Professor Carol Emslie is a medical sociologist who is co-Chair of the Scottish Alcohol Research Network. Her applied research aims to understand the social context of drinking and explore ways to reduce alcohol-related harm. Her work has featured on the BBC and in the New York Times, and she has presented her research at the Scottish Parliament. She has an international reputation for gender and alcohol research, and launched the #dontpinkmydrink social media campaign to highlight alcohol marketing to women. Recent work includes a WHO-commissioned report on gender and alcohol, and research on drinking in LGBTQ+ communities.

Professor Emslie leads the Crucible programme at Glasgow Caledonian University. This creates ‘outward facing’ early career researchers who can communicate their research to media, practitioners, and policymakers and who are committed to working with partners to deliver positive social change.

Sex Matters in Metabolic Impact of GLP-1 Analogues

October 19th, 2026 | 12pm

Dr. Karolina Skibicka

Dr. Karolina Skibicka is a Professor and Canada Research Chair Tier 1 in Neurocircuitry of Interoception at the Hotchkiss Brain Institute, University of Calgary, Canada. She previously served as an Associate Professor and Metabolic Physiology Chair in the Department of Nutritional Sciences at Penn State University, USA and a Professor of Molecular Medicine at the Institute of Neuroscience and Physiology at the University of Gothenburg, Sweden. Dr Skibicka earned her PhD in Neuroscience from the University of Pennsylvania, Pearlman School of Medicine and her postdoctoral training in Neuroendocrinology at the Sahlgrenska Academy, Sweden.

Her research approach utilizes rat models and applies a wide variety of behavioral neuroscience methodologies and levels of analysis, including behavioral, neuroanatomical, molecular, neuropharmacological, and opto and chemogenetic to investigate the neural basis of gut-brain communication.

Oral Contraceptives, Emotions and Mental Health: Let’s Be Critical!

November 9th, 2026 | 12pm

Fear is an adaptive emotion that can help us identify potentially dangerous situations. However, very high levels of fear can impair an individual’s functioning. Numerous factors—biological, psychological, and environmental—can influence our ability to learn and regulate fear. In this presentation, we will examine the role of sex differences and sex hormones, with an emphasis on oral contraceptive use, in the learning and regulation of fear. Clinical implications will also be discussed.

Dr. Marie-France Marin

Marie-France Marin holds a Ph.D. in neuroscience from the University of Montreal and completed postdoctoral training at Massachusetts General Hospital, Harvard Medical School. She directs the STEAM Lab (Stress, Trauma, Emotions, Anxiety & Memory Lab), is a professor in the Department of Psychology at the University of Quebec in Montreal, an associate professor in the Department of Psychiatry and Addiction at the University of Montreal, and a researcher at the Research Center of the Montreal University Institute of Mental Health. She holds the Canada Research Chair in Hormonal Modulation of Cognitive and Emotional Functions. Her research focuses on two main areas: one examining the mechanisms by which stress hormones and sex hormones influence cognitive and emotional processes, and the other examining the risk and protective factors influencing the development of psychopathologies in young people and vulnerable populations. Her research aims to better identify the hormonal, cognitive, and environmental factors that contribute to a person’s vulnerability to developing anxiety disorders and post-traumatic stress disorder.

Weight Stigma Across Women’s Lives: Insights from the Women’s International and Intersecting Stigma Experiences (WIISE) Study

December 14th, 2026 | 12pm

Weight stigma is a pervasive and often overlooked social determinant of health that disproportionately affects women across the life course. This presentation will introduce the concept of weight stigma and examine its prevalence and biopsychosocial impacts on women’s health and wellbeing. Drawing on findings from the Women’s International and Intersecting Stigma Experiences (WIISE) study, we will share insights from 90 narrative interviews with women living in Canada, Germany, and the United Kingdom. These narratives explore how weight stigma is experienced during key life stages, including puberty, the perinatal period, and menopause, while highlighting the unique experiences of women with intersecting marginalized identities. Finally, we will discuss current gaps in the literature and future research priorities to advance equitable, person-centred approaches that reduce stigma and improve health outcomes for women.

Dr. Taniya Nagpal

Dr. Taniya Nagpal is an Assistant Professor in the Faculty of Kinesiology, Sport, and Recreation at the University of Alberta. Her research focuses on women’s health and wellbeing and seeks to understand how psychosocial factors, especially weight stigma and health related stigma more broadly, affect health behaviours, healthcare access, and outcomes across life stages including preconception, pregnancy, postpartum and menopause.

She earned her PhD from Western University, followed by a Mitacs funded postdoctoral fellowship at the University of Ottawa and with the Society of Obstetricians and Gynaecologists of Canada, working on weight stigma in prenatal contexts including measuring and understanding implications of internalized stigma.

Dr. Nagpal’s work is marked by its intersectional, person centred approach. She is dedicated to designing inclusive interventions and translating research findings into policy and practice to reduce stigma, improve clinical care, and empower women to navigate healthcare with greater autonomy, confidence, and equitable access.

Women’s Mental Health: Considering Symptoms Profiles, Stress & Hormones

January 18th, 2027 | 12pm

Women are twice as likely to develop depression compared to men. In fact, young women in Canada (aged 15-24yr) show the highest rates of depressive episodes in the past 12-months compared to men and women of all other age groups. Moreover, depression is a heterogenous condition in which women tend to show different symptom presentations compared to men, thus examining sex and gender differences is imperative. Our lab explores transdiagnostic mental health symptom clusters in women and men, and further examines the unique psychosocial and biomarker profiles of these symptom clusters. We show that neurovegetative symptoms are more common in women and that these specific symptoms are more closely linked to inflammatory markers. In addition to inflammation, sex hormones can influence mood, which may contribute, in-part, to sex differences in depression. Our lab examines hormonal contraceptive use in young women (including different types/formulations) in relation to mood, acute stress responses and peripheral biomarker profiles. Millions of women globally use hormonal contraceptives, yet we do not fully understand their impacts on women’s mental health and neurobiology. Our work fills important gaps on understanding depression in young women and could help inform more personalized medical recommendations for young women considering hormonal contraceptives in the future.

Dr. Robyn McQuaid

Dr. Robyn McQuaid is an Associate Professor in the Department of Neuroscience at Carleton University and a Scientist at the University of Ottawa’s Institute of Mental Health Research in the Culture & Gender Research Unit. Dr. McQuaid’s research examines the impacts of stressors and traumatic experiences on mental health disorders among various populations. She examines the neuroendocrine, inflammatory and genetic/epigenetic pathways through which early-life adversity and adult stressors promote depression and comorbid conditions. A focus of her work is using biomarkers to inform future precision medicine advances for mental illness. Much of Dr. McQuaid’s research program is conducted with groups that have historically been mistreated or excluded from biological health research, which includes a large focus on women’s mental health. Dr. McQuaid is the recipient of an Ontario Early Researcher Award (ERA), The Royal Ottawa Foundation’s Inspiration Award for Young Researcher, and the IMHR’s Emerging Research Innovators In Mental Health award.

Interrogating Black-White Health Disparities over the Life course, The Role of Reproductive Aging and Menopause

February 8th, 2027 | 12pm

Dr. Alexis Reeves

Alexis is an epidemiologist broadly focused on the causes and consequences of disparities in accelerated aging. She is particularly interested in the structural and psychobiological mechanisms that may produce early health declines in minoritized populations. Much of her work has focused on the health of women, especially Black women, as they enter into life-stages, such as the midlife menopausal transition where cardio-metabolic risk is high and disparities can exacerbate. Alexis also has expertise in causal inference, and applies causal inference theory and statistical methods to these areas of research to mitigate and quantify bias. Overall, her work aims to advance health equity and support minoritized populations to thrive as they age.

Title TBD

March 8th, 2027

Dr. Riley Bove

Dr. Riley Bove is a practicing neurologist and clinician scientist in the UCSF Weill Institute for Neurosciences.

Dr. Bove is a national and international leader in sex and gender aspects of Neurology, publishing, collaborating and lecturing widely on this topic. She is PI of the first industry-sponsored Phase IV trial of a medication for use in pregnant and lactating people with MS and led the first RCT in menopausal women with MS. She is founding Director of the SAGE Neurology Program at UCSF, whose educational mission is supported by an NINDS R25 training grant. In the technology space, Dr. Bove has conducted innovative work designing, validating and implementing digital tools to improve care access, holistic measures of patient function, and as digital therapeutics. She is co-PI of the BRIDGE precision medicine dashboards that support delivery of point-of-care personalized medicine.

Dr. Bove graduated Phi Beta Kappa in anthropology from Harvard College, then conducted ethnographic study and film work on a Fulbright grant, learning from patients and families. She received her MD and MMSc from Harvard Medical School. She completed a neurology residency in the Massachusetts General/Brigham Hospitals program, followed by a clinical research fellowship at the Partners MS Center. Dr. Bove serves on the Science Committee of the American Academy of Neurology and is on the Editorial Board of Annals of Neurology and Neurology N2. Her research is supported by the NIH, Department of Defense, National MS Society, foundations and industry sources. She is committed to training the next generation of clinicians and scientists, and mentors students, doctoral and postdoctoral trainees in a variety of individualized clinical and training plans. Dr. Bove contributes to global neurology and equity initiatives through the Global Teleneurology Service and the BALANCE program.

Dr. Bove sees patients in the UCSF Multiple Sclerosis and Neuroinflammation Center where she provides comprehensive care for individuals with MS that is informed by their sex, gender, reproductive goals, and more broadly, by their life phase and goals. She speaks French and Spanish.

Headache in Pregnancy and Lactation

April 5th, 2027 | 12pm

Dr. William Kingston

Dr. Kingston is originally from Moncton, NB and completed his Neurology Residency at the University of Toronto where he served as Chief Resident. He has a subspecialty fellowship in Headache Medicine from Mayo Clinic Arizona. He is the founder and director of the headache clinic and headache in pregnancy clinic at Sunnybrook Health Sciences Centre. He founded and directs the headache medicine fellowship at Sunnybrook. He is the education site director for Adult Neurology at Sunnybrook and is also the chair of the Neurology Competency Committee. He is on the board of directors of both the Canadian Headache Society and Migraine Canada. His major clinic and research interests are in headache in pregnancy and cluster headache.

Beyond Disparities: Reimagining Black Women’s Health Through Equity and Structural Change

May 3rd, 2027 | 12pm

For decades, research has documented that Black women experience poorer health outcomes across multiple domains including mental health, maternal health, HIV, chronic disease, and access to care. Yet despite growing evidence, these inequities persist. The problem is not a lack of knowledge about disparities but a failure to transform the structures that produce them.  This presentation argues that improving Black women’s health requires moving beyond documenting disparities toward redesigning systems, policies, research practices, and models of care that promote equity and wellbeing.

Dr. Notisha Massaquoi

Dr. Notisha Massaquoi is an Assistant Professor in the Department of Health and Society at the University of Toronto Scarborough, with cross-appointments in the Factor-Inwentash Faculty of Social Work and the Temerty Faculty of Medicine. She is the Founder and Director of the Black Health Equity Lab (BHEL), a community-engaged research lab dedicated to advancing health equity for Black communities through collaborative research, advocacy, strategic initiatives, and program development.

 

 

Newsletter Sign Up

Keep up to date with the Women's Health Research Cluster